acetylleucyl-leucyl-norleucinal has been researched along with Brain Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pajonk, F; Vlashi, E | 1 |
| Piette, J; Piret, B; Schoonbroodt, S | 1 |
| Ikemoto, H; Kitagawa, H; Matsumoto, T; Tani, E | 1 |
3 other study(ies) available for acetylleucyl-leucyl-norleucinal and Brain Neoplasms
| Article | Year |
|---|---|
Targeted cancer stem cell therapies start with proper identification of the target.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Culture Techniques; Cysteine Proteinase Inhibitors; Drug Resistance, Neoplasm; Glioma; Humans; Leupeptins; Neoplastic Stem Cells; Phenotype; Proteasome Endopeptidase Complex; Reproducibility of Results | 2010 |
The ATM protein is required for sustained activation of NF-kappaB following DNA damage.
Topics: Adolescent; Age Factors; Antineoplastic Agents, Phytogenic; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Brain Neoplasms; Camptothecin; Cell Cycle Proteins; Cells, Cultured; Child; Child, Preschool; DNA Damage; DNA-Activated Protein Kinase; DNA-Binding Proteins; Enzyme Inhibitors; Fibroblasts; Gene Expression Regulation; Glioblastoma; Humans; I-kappa B Proteins; Leupeptins; NF-kappa B; NF-KappaB Inhibitor alpha; Nuclear Proteins; Phosphoric Monoester Hydrolases; Protease Inhibitors; Protein Serine-Threonine Kinases; Proteins; Radiation Tolerance; Recombinant Fusion Proteins; Topoisomerase I Inhibitors; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 1999 |
Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells.
Topics: Acetylcysteine; Apoptosis; Base Sequence; Brain Neoplasms; Cysteine Proteinase Inhibitors; DNA Primers; Fas Ligand Protein; fas Receptor; Glioma; Humans; Leupeptins; Membrane Glycoproteins; Proto-Oncogene Proteins c-myc; Tumor Cells, Cultured | 2001 |